Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | RAB9A | P51151 | 7/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.51 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.50 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7795900 | 0.89 | PKN1 (0.64) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL9306370 | 0.87 | ESR1 (0.49) | ALDH1A1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL6169066 | 0.86 | HCRTR1 (0.56) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL6217364 | 0.84 | KDM4E (0.50) | ALDH1A1RAB9AKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL11824061 | 0.83 | SIRT2 (0.56) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL11148656 | 0.83 | HCRTR1 (0.53) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL16182400 | 0.83 | L3MBTL1 (0.38) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL12393020 | 0.82 | ALDH1A1 (0.54) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL12393006 | 0.82 | HRH3 (0.56) | HCRTR1ALDH1A1RAB9AKDM4EMAPT | |
| SCHEMBL14473811 | 0.82 | ALDH1A1 (0.53) | HCRTR1ALDH1A1RAB9AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116930150-A | Hydrogen sulfide Raman sensing analysis method based on Au-Ag Janus NPs | 无锡国盛生物工程股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20160115136-A1 | COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2016-04-28 | — | — | US | disclosed |
| WO-2014160405-A1 | COMPOUNDS, COMPOSITIONS COMPRISING SAME, AND METHODS RELATED THERETO | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2014-10-02 | — | — | WO | disclosed |
| US-8283561-B2 | Quantum dot solar cell | HONEYWELL INTERNATIONAL INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-20090283142-A1 | QUANTUM DOT SOLAR CELL | HONEYWELL INTERNATIONAL INC. (US) | 2009-11-19 | — | — | US | disclosed |
| EP-0742210-B1 | 2-MERCAPTOBENZIMIDAZOLE DERIVATIVE AND ANTIHYPERLIPEMIC OR ANTIARTERIOSCLEROTIC AGENT CONTAINING THE SAME | FUJI PHOTO FILM CO LTD (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-6288236-B1 | PREVENTIVE AND THERAPEUTIC MEDICAMENT FOR HYPERLIPEMIA OR ARTERIAL SCLEROSIS. | FUJI PHOTO FILM CO., LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| WO-2001034573-A1 | COMPOUNDS | ASTRAZENECA AB (SE) | 2001-05-17 | — | — | WO | disclosed |
| US-6174907-B1 | THERAPY AND PROPHYLAXIS OF HYPERLIPEMIA OR ARTERIAL SCLEROSIS; AS ADDITIVE OF A SILVER HALIDE PHOTOSENSITIVE MATERIAL, LIQUID CRYSTAL MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| US-5998456-A | ANTILIPEMIC AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0849259-A1 | BENZIMIDAZOLE COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 1998-06-24 | — | — | EP | disclosed |
| EP-0742210-A1 | 2-MERCAPTOBENZIMIDAZOLE DERIVATIVE AND ANTIHYPERLIPEMIC OR ANTIARTERIOSCLEROTIC AGENT CONTAINING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1996-11-13 | — | — | EP | disclosed |
| US-5430042-A | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use | AKTIEBOLAGET ASTRA (SE) | 1995-07-04 | — | — | US | disclosed |
| EP-0593463-A1 | DIALKOXY-PYRIDINYL-BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | AKTIEBOLAGET ASTRA (SE) | 1994-04-27 | — | — | EP | disclosed |
| EP-0535081-A1 | SUBSTITUTED BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | AKTIEBOLAGET ASTRA (SE) | 1993-04-07 | — | — | EP | disclosed |
| EP-0287971-B1 | BENZIMIDAZOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATIONS | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1993-02-24 | — | — | EP | disclosed |
| WO-1991019711-A1 | SUBSTITUTED BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | AKTIEBOLAGET ASTRA (SE) | 1991-12-26 | — | — | WO | disclosed |
| WO-1991019712-A1 | DIALKOXY-PYRIDINYL-BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | AKTIEBOLAGET ASTRA (SE) | 1991-12-26 | — | — | WO | disclosed |
| US-4942245-A | ANTIALLERGIC AGENTS, ANTIASTHMATICS, RHINITIS, CONJUNCTIVITIS | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1990-07-17 | — | — | US | disclosed |
| EP-0287971-A2 | Benzimidazole derivatives and process for their preparations | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115136-A1 | COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO | LPO, NOTUM, FARS2 | HCRTR1 3282/4885ALDH1A1 1503/4885RAB9A 3735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.